---
category: news
title: "BioXcel Therapeutics Receives FDA Breakthrough Therapy Designation for BXCL501 for the Acute ..."
excerpt: "BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,"
publishedDateTime: 2021-03-15T11:02:00Z
originalUrl: "https://apnews.com/press-release/globenewswire-mobile/business-products-and-services-government-regulations-drug-approvals-coronavirus-pandemic-f497a4cc88cc898cfc0ec4cd0d14d3bc"
webUrl: "https://apnews.com/press-release/globenewswire-mobile/business-products-and-services-government-regulations-drug-approvals-coronavirus-pandemic-f497a4cc88cc898cfc0ec4cd0d14d3bc"
type: article

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "yVKah9XP8WzDyQvMKBx9cz61ID8pZ5Su9jEyvzUGSBNn8LPgyHyJuCrRUVEzfIwoiAZXkhUTX4PrjQkXKJKCnqoNvUnavbnPOaGXnqfNWuO/YS2AmOgkTqlKtrm5yPBkiphcApV9ZosAZUEjcMfN40A9rPLN7L+wyKDwQs4xT6/NXhKQ9ekj5DOuMa5KifJJxOQpWnTd6pSuROzQeDmRaUzk+bnw3wTiMzfTXfxVgjpw3pJDGrdVoX6cHSSs40Jq96fMEMhJ5PR0b4lcLmcrl3R8EUhvqnRxozXSSBcYDTs+3y72DIv4/umpaf6BpKpgFYLRG0IuL+iLVeH/j1R4SFMBG8VSNMNlYtTMpKp920M=;urn1zyZEohsOUh7lOHnSYA=="
---

